Gail Walkinshaw Selected Research

Gail Walkinshaw Research Topics

Disease

15	Hypoxia (Hypoxemia) 01/2020 - 05/2009
5	Inflammation (Inflammations) 01/2022 - 04/2016
4	Insulin Resistance 01/2022 - 10/2014
3	Ischemia 01/2014 - 07/2009
2	Anemia 01/2020 - 04/2016
2	Obesity 04/2016 - 10/2014
1	Hypertrophy 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Hyperglycemia 01/2022
1	Iron Deficiencies 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Alcoholic Fatty Liver 01/2019
1	Fatty Liver 01/2019
1	Atherosclerosis 04/2016
1	Atherosclerotic Plaque (Atheroma) 04/2016
1	Weight Gain 04/2016
1	Edema (Dropsy) 01/2014
1	Ischemic Stroke 01/2014
1	Brain Ischemia (Cerebral Ischemia) 01/2014
1	Brain Injuries (Brain Injury) 09/2013
1	Brain Diseases (Brain Disorder) 09/2013
1	Wounds and Injuries (Trauma) 09/2013
1	Stroke (Strokes) 09/2013
1	Epilepsy (Aura) 09/2013

Drug/Important Bio-Agent (IBA)

7	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 12/2019 - 10/2012
6	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2009
5	Oxygen (Dioxygen)IBA 01/2020 - 05/2009
5	FG-4497IBA 04/2016 - 07/2009
3	Messenger RNA (mRNA)IBA 01/2022 - 07/2012
3	CholesterolIBA 01/2022 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2013
3	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 01/2014
2	Prolyl-Hydroxylase InhibitorsIBA 01/2020 - 09/2013
2	Erythropoietin FDA Link 01/2020 - 01/2014
2	EnzymesIBA 12/2019 - 01/2017
2	cobaltous chloride (cobalt(II)chloride)IBA 04/2015 - 05/2009
2	Neuroprotective AgentsIBA 09/2013 - 07/2012
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	roxadustatIBA 01/2020
1	Choline (Choline Chloride)IBA 01/2020
1	FructoseIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	IronIBA 01/2020
1	MetalsIBA 01/2020
1	Methionine (L-Methionine)FDA Link 01/2020
1	Peptidoglycan (Murein)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Cytochromes b (Cytochrome b)IBA 01/2020
1	HepcidinsIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	oxidized low density lipoproteinIBA 04/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2016
1	AutoantibodiesIBA 04/2016
1	LDL Receptors (LDL Receptor)IBA 04/2016
1	CopperIBA 04/2016
1	LipidsIBA 04/2016
1	Endothelins (Endothelin)IBA 04/2015
1	MimosineIBA 04/2015
1	Endothelin-Converting EnzymesIBA 04/2015
1	IsoenzymesIBA 10/2014
1	OccludinIBA 01/2014
1	Hypoxia-Inducible Factor-Proline DioxygenasesIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Tight Junction ProteinsIBA 01/2014
1	activin AIBA 09/2013
1	Activins (Activin)IBA 09/2013
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2013
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2013
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2012
1	Hemeproteins (Heme Protein)IBA 07/2012
1	NeuroglobinIBA 07/2012
1	dimethyloxallyl glycineIBA 05/2009
1	Deferoxamine (Desferal)FDA LinkGeneric 05/2009
1	Ciclopirox (Loprox)FDA LinkGeneric 05/2009

Therapy/Procedure

2	Therapeutics 01/2019 - 10/2014
1	Nephrectomy 01/2020